Kevan Polkinghorne. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anticoagulants/therapeutic useArteriovenous Shunt, Surgical/adverse effectsArteriovenous Shunt, Surgical/standardsBlood Vessel Prosthesis Implantation/adverse effectsBlood Vessel Prosthesis Implantation/standardsDrug Therapy, CombinationEvidence-Based MedicineFibrinolytic Agents/therapeutic useGraft Occlusion, Vascular/etiologyGraft Occlusion, Vascular/physiopathologyGraft Occlusion, Vascular/prevention & controlHumansPlatelet Aggregation Inhibitors/therapeutic useRandomized Controlled Trials as TopicRenal Dialysis/standardsThrombosis/etiologyThrombosis/physiopathologyThrombosis/prevention & controlTreatment OutcomeVascular Patency/drug effects
Substances： See more » AnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors
Year: 2008 PMID： 18713119 DOI： 10.1111/j.1440-1797.2008.00993.x
Source DB: PubMed Journal: Nephrology (Carlton) ISSN： 1320-5358 Impact factor: 2.506